Document is current
Any future updates will be listed below
-
Authors
Du, Li https://orcid.org/0000-0002-4215-3801
Liu, Wei
Aldana-Masangkay, Grace
Pozhitkov, Alex
Pichiorri, Flavia
Chen, Yuan
Rosen, Steven T.
-
Funding
Funding for this research was provided by:
national institute of health (P30CA033572, R01GM086171, R01CA212119)
- License Information
-
More Information
Article History
Received: 6 August 2021
Accepted: 16 December 2021
First Online: 4 January 2022
Declarations
:
: All MM bone marrow samples were obtained from patients at the City of Hope National Medical Center with informed patient consent, under Research Ethics Board approval at City of Hope protocol (IRB 15150) in accordance with assurances filed with and approved by the Department of Health and Human Services, and meeting all requirements of the Declaration of Helsinki. All experiments using mice were approved by the Beckman Research Institute Animal Care and Use Committee (IACUC #10026) and complied with all relevant federal guidelines and institutional policies.
: Not applicable.
: Y.C. reports equity ownership, Board of Director and consulting fees from Oncovalent Therapeutics, Inc. outside the submitted work. All other authors declare that they have no conflict of interest.
